This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights Altria, Las Vegas Sands, Molson Coors Beverage, Wynn Resorts and Philip Morris International
by Zacks Equity Research
Altria, Las Vegas Sands, Molson Coors Beverage, Wynn Resorts and Philip Morris International are part of the Zacks top Analyst Blog.
Resilient Sin Stocks to Power Up Your Investment Portfolio
by Rajani Lohia
Sin stocks are poised to thrive in any market, offering stability, strong cash flow and high returns. Discover three top picks poised to boost your portfolio gains.
Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPYD
Should Franklin U.S. Low Volatility High Dividend Index ETF (LVHD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for LVHD
MO Stock Up 5% in a Month: Lock in Gains or Hold for More Upside?
by Ansuiya Mohta
Altria's focus on innovation and its transition to reduced-risk products provide an upside, although risks from illicit market growth remain.
Why Earnings Season Matters
by Derek Lewis
Earnings season is undoubtedly hectic for market participants, with companies finally revealing what's transpired behind closed doors.
The Zacks Analyst Blog Philip Morris, Booking Holdings, Anheuser-Busch InBev, Elite Pharmaceuticals and National Research
by Zacks Equity Research
Philip Morris, Booking Holdings, Anheuser-Busch InBev, Elite Pharmaceuticals and National Research are included in this Analyst Blog.
Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPS
Top Stock Reports for Philip Morris, Booking Holdings & Anheuser-Busch
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Philip Morris International Inc. (PM), Booking Holdings Inc. (BKNG) and Anheuser-Busch InBev SA/NV (BUD), as well as two micro-cap stocks Elite Pharmaceuticals, Inc. (ELTP) and National Research Corp. (NRC).
McCormick Set to Release Q1 Earnings: Should You Expect a Beat?
by Zacks Equity Research
MKC's Q1 results are likely to reflect growth from volume, product mix and cost-saving initiatives, but high costs pose risks.
Should Invesco S&P 100 Equal Weight ETF (EQWL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EQWL
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
by Zacks Equity Research
Sector ETF report for RSPS
Why Philip Morris (PM) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should JPMorgan Diversified Return U.S. Equity ETF (JPUS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JPUS
Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for GSEW
Zacks Investment Ideas feature highlights: Coca-Cola, Philip Morris and Johnson & Johnson
by Zacks Equity Research
Coca-Cola, Philip Morris and Johnson & Johnson are part of the Zacks Investment Ideas article.
3 Dividend Kings Shaking Off Market Woes
by Derek Lewis
While the market throws its tariff tantrum, several long-established companies with years of operational success have seen their shares move higher, displaying relative strength.
3 Stocks to Buy for Post-Earnings Momentum
by Derek Lewis
All three of these companies posted results that pleased the market, with shares climbing post-earnings as a result. Will the momentum continue?
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Is Altria Stock a Buy, Sell or Hold at a P/E Multiple of 10.29X?
by Ansuiya Mohta
MO presents an attractive valuation with growth potential. But investors should be cautious of challenges like increasing competition and declining cigarette shipments.
Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DHS
Stock Market News for Feb 7, 2025
by Zacks Equity Research
U.S. stock markets closed mixed on Thursday after a choppy session.
Philip Morris Q4 Earnings & Sales Beat Estimates, Stock Rallies
by Zacks Equity Research
PM's fourth-quarter 2024 results reflect increased earnings and sales on robust momentum across all regions.
Philip Morris (PM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Philip Morris (PM) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Philip Morris (PM) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 2.65% and 3.67%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?